v3.22.4
COMPENSATION PLANS (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Option Activity
The following table summarizes the Company’s option activity during the years ended December 31, 2022, 2021 and 2020:
Years ended December 31 2022 2021 2020
(shares in thousands) Shares Weighted
Average
Exercise
Price
Shares Weighted
Average
Exercise
Price
Shares Weighted
Average
Exercise
Price
Outstanding beginning of year 368  $ 43.72  1,015  $ 43.88  536  $ 45.11 
Granted during the year     —  —  495  42.87 
Forfeited during the year (1) 41.33  (32) 41.33  (4) 53.83 
Exercised during the year (5) 41.33  (615) 44.11  (12) 53.83 
Outstanding end of year 362  $ 43.76  368  $ 43.72  1,015  $ 43.88 
Vested Options:
Vested during the year 161  $ 42.98  248  $ 46.70  115  $ 50.46 
Eligible end of year for exercise 223  $ 44.25  67  $ 47.05  439  $ 43.19 
Aggregate intrinsic value ($ in thousands):
Total options outstanding $ 6,204  $ 13,593  $ 24,838 
Options exercisable $ 3,716  $ 2,268  $ 11,047 
Options exercised $ 91  $ 26,348  $ 97 
Weighted average fair value of options granted during the year N/A N/A $ 15.17 
The following table summarizes the Company’s SARS activity during the years ended December 31, 2022, 2021 and 2020:
Years ended December 31 2022 2021 2020
(shares in thousands) Shares Weighted
Average
Exercise
Price
Shares Weighted
Average
Exercise
Price
Shares Weighted
Average
Exercise
Price
Total SARS:
Outstanding beginning of year 224  $ 64.33  485  $ 56.96  535  $ 54.53 
Forfeited during the year     —  —  (10) 68.01 
Exercised during the year     (261) 50.63  (40) 22.39 
Outstanding end of year 224  $ 64.33  224  $ 64.33  485  $ 56.96 
Vested SARS:
Vested during the year   $   85  $ 63.86  115  $ 60.71 
Eligible end of year for exercise 224  $ 64.33  224  $ 64.33  404  $ 55.58 
Aggregate intrinsic value ($ in thousands):
Total SARS outstanding $ 383  $ 3,669  $ 6,032 
SARS exercisable $ 383  $ 3,669  $ 5,540 
SARS exercised $   $ 9,045  $ 1,918 
Weighted average fair value of SARS granted during the year N/A N/A N/A
Schedule of Black-scholes Model for Awards Granted
The following table presents assumptions used in the Black-Scholes model for the stock options granted in 2020. There were no stock options granted in 2022 and 2021.
  2020
Dividend rate 2.37  %
Risk-free interest rate 0.65  %
Expected option life (years) 5.0
Price volatility 42.42  %
Schedule of Award Activity
The following table summarizes the activity for restricted stock for the years ended December 31, 2022, 2021 and 2020:  
  2022 2021 2020
(shares in thousands) Shares Weighted-Average
Grant Date
Stock Price
Shares Weighted-Average
Grant Date
Stock Price
Shares Weighted-Average
Grant Date
Stock Price
Unvested beginning of year 929  $ 55.06  790  $ 50.39  738  $ 49.65 
Granted during the year 254  64.62  371  67.27  309  55.03 
Vested during the year (408) 43.23  (198) 60.05  (178) 52.80 
Forfeited during the year (17) 66.30  (34) 50.37  (79) 55.87 
Unvested end of year 758  $ 64.38  929  $ 55.06  790  $ 50.39